Network security and environmental sustainability (potential pollution from electronic waste) are also critical issues every smart solution must address, says Beth DiLauri-McBride, Chronic Portfolio Marketing Director, BD Medical-Pharmaceutical Systems
The Phase 3 TRIUMPH-4 trial ran for 68 weeks with continued weight loss throughout, suggesting the plateau has not yet been reached at this timepoint (Lilly TRIUMPH-4 Press Release)
The abdomen is the go-to injection site for most people on semaglutide
potential FDA submission 2028 (estimated): Possible FDA approval and commercial availability In the meantime, FDA-approved weight loss medications are available now
Nicotine Tob Res
Some GLP-1 medications have demonstrated cardiovascular benefits in clinical trials (such as LEADER for liraglutide, SUSTAIN-6 for semaglutide, and REWIND for dulaglutide), and discontinuation may result in loss of these protective effects